United States · FDA National Drug Code directory
Lidocaine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-079_ead2e17d-c777-57a3-e053-2995a90af78b
- Product NDC
- 76420-079
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Lidocaine Hydrochloride
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130314
- Source listing expiry
- 20261231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 mL in 1 AMPULE (76420-079-01) · 76420-079-01
- 10 AMPULE in 1 CARTON (76420-079-10) / 2 mL in 1 AMPULE · 76420-079-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →